BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15121323)

  • 1. A global perspective on vaccine safety.
    Duclos P
    Vaccine; 2004 May; 22(15-16):2059-63. PubMed ID: 15121323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation safety: a priority of the World Health Organization's Department of Vaccines and Biologicals.
    Duclos P; Hofmann CA
    Drug Saf; 2001; 24(15):1105-12. PubMed ID: 11772144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization safety priority project at the World Health Organization.
    Duclos P; Delo A; Aguado T; Bilous J; Birmingham M; Kieny MP; Milstien J; Wood D; Tarantola D
    Semin Pediatr Infect Dis; 2003 Jul; 14(3):233-9. PubMed ID: 12913836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry.
    Robertson SE; Mayans MV; Horsfall S; Wright PF; Clemens J; Ivanoff B; Lambert PH
    Bull World Health Organ; 1997; 75(4):295-305. PubMed ID: 9342888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Global immunization policies and recommendations: objectives and process].
    Duclos P; Okwo-Bele JM
    Med Sci (Paris); 2007 Apr; 23(4):409-16. PubMed ID: 17433232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.
    Peter G; des Vignes-Kendrick M; Eickhoff TC; Fine A; Galvin V; Levine MM; Maldonado YA; Marcuse EK; Monath TP; Osborn JE; Plotkin S; Poland GA; Quinlisk MP; Smith DR; Sokol M; Soland DB; Whitley-Williams PN; Williamson DE; Breiman RF
    Pediatrics; 1999 Oct; 104(4 Pt 1):942-50. PubMed ID: 10506239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination vaccines: postlicensure safety evaluation.
    Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New challenges in assuring vaccine quality.
    Dellepiane N; Griffiths E; Milstien JB
    Bull World Health Organ; 2000; 78(2):155-62. PubMed ID: 10743279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
    Amarasinghe A; Black S; Bonhoeffer J; Carvalho SM; Dodoo A; Eskola J; Larson H; Shin S; Olsson S; Balakrishnan MR; Bellah A; Lambach P; Maure C; Wood D; Zuber P; Akanmori B; Bravo P; Pombo M; Langar H; Pfeifer D; Guichard S; Diorditsa S; Hossain MS; Sato Y
    Vaccine; 2013 Apr; 31 Suppl 2():B108-14. PubMed ID: 23598471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability evaluation of vaccines: WHO approach.
    Knezevic I
    Biologicals; 2009 Nov; 37(6):357-9; discussion 421-3. PubMed ID: 19729320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002.
    Allred NJ; Shaw KM; Santibanez TA; Rickert DL; Santoli JM
    Am J Prev Med; 2005 Feb; 28(2):221-4. PubMed ID: 15710279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
    Chen RT
    Vaccine; 2004 May; 22(15-16):2047-53. PubMed ID: 15121321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of immunization injections in Africa: not simply a problem of logistics.
    Dicko M; Oni AQ; Ganivet S; Kone S; Pierre L; Jacquet B
    Bull World Health Organ; 2000; 78(2):163-9. PubMed ID: 10743280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: the scientific basis of regulatory expectations pre- and post-licensure.
    Wood D; Shin JH; Duval B; Schmitt HJ
    Vaccine; 2006 Aug; 24 Suppl 3():S3/187-92. PubMed ID: 16950006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technologies that make administration of vaccines safer.
    Clements CJ; Larsen G; Jodar L
    Vaccine; 2004 May; 22(15-16):2054-8. PubMed ID: 15121322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring vaccine safety in immunization programmes--a WHO perspective.
    Jodar L; Duclos P; Milstien JB; Griffiths E; Aguado MT; Clements CJ
    Vaccine; 2001 Feb; 19(13-14):1594-605. PubMed ID: 11166881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.